中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs

文献类型:期刊论文

作者Li, Gui-Rong2,3; Wang, Hong-Bing1; Qin, Guo-Wei1; Jin, Man-Wen4; Tang, Qiang4; Sun, Hai-Ying3; Du, Xin-Ling; Deng, Xiu-Ling3; Zhang, Xiao-Hua4; Chen, Jing-Bo4
刊名CIRCULATION
出版日期2008-05-13
卷号117期号:19页码:2449-2457
关键词arrhythmia drugs electrophysiology pharmacology ion channels
ISSN号0009-7322
DOI10.1161/CIRCULATIONAHA.108.769554
文献子类Article
英文摘要Background-The development of atrium-selective antiarrhythmic agents is a current strategy for inhibiting atrial fibrillation (AF). The present study investigated whether the natural flavone acacetin from the traditional Chinese medicine Xuelianhua would be an atrium-selective anti-AF agent. Methods and Results-The effects of acacetin on human atrial ultrarapid delayed rectifier K+ current (I-Kur) and other cardiac ionic currents were studied with a whole-cell patch technique. Acacetin suppressed IKur and the transient outward K+ current (IC50 3.2 and 9.2 mu mol/L, respectively) and prolonged action potential duration in human atrial myocytes. The compound blocked the acetylcholine-activated K+ current; however, it had no effect on the Na+ current, L-type Ca2+ current, or inward-rectifier K+ current in guinea pig cardiac myocytes. Although acacetin caused a weak reduction in the hERG and hKCNQ1/hKCNE1 channels stably expressed in HEK 293 cells, it did not prolong the corrected QT interval in rabbit hearts. In anesthetized dogs, acacetin (5 mg/kg) prolonged the atrial effective refractory period in both the right and left atria 1 to 4 hours after intraduodenal administration without prolongation of the corrected QT interval, whereas sotalol at 5 mg/kg prolonged both the atrial effective refractory period and the corrected QT interval. Acacetin prevented AF induction at doses of 2.5 mg/kg (50%), 5 mg/kg (85.7%), and 10 mg/ kg (85.7%). Sotalol 5 mg/ kg also prevented AF induction (60%). Conclusions-The present study demonstrates that the natural compound acacetin is an atrium- selective agent that prolongs the atrial effective refractory period without prolonging the corrected QT interval and effectively prevents AF in anesthetized dogs after intraduodenal administration. These results indicate that oral acacetin is a promising atrium- selective agent for the treatment of AF.
WOS关键词CONGESTIVE-HEART-FAILURE ; CELL-CYCLE PROGRESSION ; RECTIFIER K+ CURRENT ; I-KUR ; VENTRICULAR MYOCYTES ; CHANNELS ; BLOCKER ; AVE0118 ; CONTRACTILITY ; MECHANISMS
WOS研究方向Cardiovascular System & Cardiology
语种英语
WOS记录号WOS:000255776700005
出版者LIPPINCOTT WILLIAMS & WILKINS
源URL[http://119.78.100.183/handle/2S10ELR8/272917]  
专题天然药物化学研究室
通讯作者Li, Gui-Rong
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China;
2.Univ Hong Kong, Dept Physiol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China;
3.Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China;
4.Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Peoples R China;
5.Univ Hong Kong, Grantham Hosp, Cardiothorac Unit, Hong Kong, Hong Kong, Peoples R China;
6.Univ Hong Kong, Dept Pharmacol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China
推荐引用方式
GB/T 7714
Li, Gui-Rong,Wang, Hong-Bing,Qin, Guo-Wei,et al. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs[J]. CIRCULATION,2008,117(19):2449-2457.
APA Li, Gui-Rong.,Wang, Hong-Bing.,Qin, Guo-Wei.,Jin, Man-Wen.,Tang, Qiang.,...&Lau, Chu-Pak.(2008).Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs.CIRCULATION,117(19),2449-2457.
MLA Li, Gui-Rong,et al."Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs".CIRCULATION 117.19(2008):2449-2457.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。